For 2007, the WHO estimated 511,000 cases of multidrug-resistant (MDR)-TB, representing approximately 5% of all TB cases worldwide. Extensively drug-resistant (XDR-TB) strains have been detected ...
The present decade has seen a reawakening of tuberculosis (TB) drug research and development (R&D), spurred on by an urgent need to stem the tide of the disease globally and develop new, more ...
From this perspective, Reichman provides vivid, detailed and sometimes excruciating accounts of a recent successful battle in the war—the victory over multi-drug resistant (MDR) TB during the ...
the Manchester team set about trying to find alternative drugs that could be used to treat these multi-drug resistant varieties of TB, known as MDR-TB. "We knew that the TB bacterium was a clever ...
In 2018, 21.5 lakh tuberculosis (TB) cases were reported to the government, as compared to 18 lakh in 2017, an increase of 17 per cent in one year. A new drug known as delamanid would be ...
First discovered in 1956 in Great Britain, MDR TB is a strain of TB that is resistant to more than one anti-TB drug and is the most known potent drug against the disease. It is different from drug ...
India is is the global TB epicentre - the country records 2.8 million new tuberculosis cases annually, of which more than 100,000 are multi-drug resistant (MDR), according to the World Health ...
Then the TB bacteria acquired immunity to many drugs, spreading rapidly among homeless people, AIDS patients, and other vulnerable groups in the United States and abroad. Several drugs can cure TB ...